Summary
| Therapy by functional class (NYHA) (currently available in Switzerland) | |||
| Recommendation, evidence | Class II | Class III | Class IV |
| I, A | Ambrisentan Bosentan Sildenafil | Ambrisentan Bosentan Sildenafil IV Epoprostenol inhaled Iloprost | IV Epoprostenol |
| I, B | SC Treprostinil | ||
| I, C | Transplantation | Transplantation | |
| IIa, C | IV Iloprost IV Treprostini | Ambrisentan Bosentan Sildenafil Inhaled/IV Iloprost SC/IV Treprostinil Combination Therapy | |
Druckversion
Suche
SSPH Research Prize 2012
Deadline for submission: April 30, 2012
Further information
Symposium "pulmonal-arterielle Hypertension im Kindesalter"
Donnerstag, 10. Mai 2012, 16.00-18.00, Bern
Further information:
5th International Congress of the Swiss Society of Pulmonary Hypertension (SSPH)
28.-29. September 2012, Thun, Congress Hotel Seepark Thun
Informationen: www.imk.ch/sgph2012
mehr